Navigation Links
What green algae are up to in the dark
Date:2/14/2013

How green algae produce hydrogen in the dark is reported by biologists at the Ruhr-Universitt Bochum in the "Journal of Biological Chemistry". Hereby, they have uncovered a mechanism for the production of the gas which has hardly been examined before; usually, researchers are interested in light-driven hydrogen synthesis. "Hydrogen could help us out of the energy crisis", says Prof. Dr. Thomas Happe, head of the working group Photobiotechnology. "If you want to make green algae produce more hydrogen, it is important to understand all the production pathways."

Green algae produce hydrogen under stress - even in the dark

Single-celled green algae of the type Chlamydomonas are microscopically small organisms: ten of them fit side by side on a human hair. In some ways, microalgae are not so very different from higher plants, such as trees. For example, they also perform photosynthesis. Unlike land plants, they can use light energy for the production of molecular hydrogen (H2). "However, Chlamydomonas and co only form hydrogen under stress", says Thomas Happe. "The disposal of the energy-rich gas serves as a kind of overflow valve so that excess light energy does not damage the sensitive photosynthetic apparatus." Chlamydomonas can also produce hydrogen in the dark. Although this fact has been known for decades, H2 synthesis in the absence of light has barely been studied because much less of the gas is produced in the dark than in the light. Moreover, it is complicated to isolate large quantities of the key enzyme of the dark-reaction, the so-called pyruvate:ferredoxin oxidoreductase. The RUB researchers nevertheless tackled the project.

Hydrogen production in the dark mimicked in vitro

Happe's team reconstructed the core of the dark hydrogen production in vitro, thus demonstrating the underlying mechanism. In order to get to the proteins involved, the researchers had these produced by bacteria. First they introduced the corresponding genes of the green algae into the gut bacterium Escherichia coli, for example, the gene for the pyruvate:ferredoxin oxidoreductase. E. coli then produced the proteins according to this blueprint. Happe's team isolated them from the bacterial cells and examined them like a construction kit. In the test tube, the biologists analysed how different combinations of proteins interacted with each other under specific environmental conditions.

"Ancient enzyme" discovered

In so doing, they found out that, under stress in the dark, the algae switch to a metabolic pathway which is normally only found in bacteria or single-celled parasites. "Chlamydmonas has an evolutionarily ancient enzyme", explains Jens Noth from the working group Photobiotechnology. "With the help of vitamin B1 and iron atoms, it gains energy from the breakdown of sugars." This energy is then used by other green algal enzymes, the hydrogenases, to form hydrogen. The unicellular microalgae switch on this metabolic pathway when they suddenly encounter oxygen-free conditions in the dark. Because, like humans, the green algae need oxygen to breathe if they cannot draw their energy from sunlight. The formation of hydrogen in the dark helps the cells to survive these stress condition. "With this knowledge, we have now found another piece of the puzzle to get an accurate picture of H2 production in Chlamydomonas", says Thomas Happe. "In future, this could also help to increase the biotechnologically relevant light-dependent H2 formation rate."


'/>"/>
Contact: Prof. Dr. Thomas Happe
thomas.happe@rub.de
49-234-322-7026
Ruhr-University Bochum
Source:Eurekalert

Related biology news :

1. Cities can reduce greenhouse gas emissions by 70 percent, says U of T researcher
2. New guide will allow electric utilities to develop Green Button Web tools
3. Aarhus University builds research station in North Greenland
4. In beef production, cow-calf phase contributes most greenhouse gases
5. Analysis of Greenland ice cores adds to historical record and provide glimpse into climates future
6. Toward reducing the greenhouse gas emissions of the Internet and telecommunications
7. Ancient red dye powers new green battery
8. Rice cultivates green batteries from plant
9. Fire and ice: Wildfires darkening Greenland snowpack, increasing melting
10. Greenphire CEO Sam Whitaker speaks on Sunshine Act and Clinical Trial Payments
11. An energy conscious workforce: New research looks at how to encourage staff to go green
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
(Date:2/6/2017)... -- According to Acuity Market Intelligence, ongoing concerns ... continue to embrace biometric and digital identification based ... Control (ABC) eGates and 1436 Automated Passport Control ... ports of entry across the globe. Deployments increased ... CAGR of 37%. APC Kiosks reached 75% growth ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... FRANCISCO , Feb. 24, 2017 Symic ... is developing a new category of therapeutics, announced today ... of SB-030 in peripheral artery disease. The trial will ... administered single-use therapeutic, in the reduction of restenosis following ... this critical development milestone for SB-030," said Nathan ...
(Date:2/24/2017)... ... February 24, 2017 , ... FireflySci, Inc is an explosive small ... FireflySci had the goal of bringing their powerful cuvette and spectrophotometer calibration ... path that FireflySci is going on as they add yet another mark on the ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is formalizing ... an array of biochemical analyses critical for Lead Discovery. The company’s Lead ... SAR programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor residence ...
Breaking Biology Technology: